Investment Rating - The report maintains a "B" rating for the new materials sector, indicating a leading performance compared to the market [1]. Core Insights - The new materials sector has shown resilience, with the new materials index rising by 0.86%, outperforming the ChiNext index by 2.54% during the week [3]. - The vitamin sector is experiencing a price surge due to geopolitical tensions in the Middle East, particularly affecting the Hormuz Strait, which has led to increased costs across the petrochemical supply chain [5]. - Key vitamin products such as Vitamin A and E have seen significant price increases, with Vitamin A reaching 110,000 CNY/ton (up 15.79% week-on-week) and Vitamin E at 101,000 CNY/ton (up 18.82% week-on-week) [5]. Summary by Sections Market Performance - The new materials sector has outperformed the broader market indices, with specific segments like battery chemicals rising by 10.69% and industrial gases by 1.78% [3][12]. - Over the past five trading days, the synthetic biology index fell by 0.92%, while semiconductor materials dropped by 2.80% [3][16]. Price Tracking - Amino acids have shown stable prices, with valine at 14,550 CNY/ton and arginine at 23,250 CNY/ton [4]. - The price of Vitamin A has increased significantly, reflecting a broader trend of rising prices in the vitamin sector due to supply constraints [4][5]. Investment Recommendations - The report suggests focusing on companies within the vitamin supply chain, such as New Hope Liuhe, Andisoo, Meihua Biological, and Zhejiang Medicine, as they are expected to benefit from the ongoing price increases [5][6].

Group 1 - The company reported a revenue of HKD 2.279 billion for the year ending December 31, 2025, representing a year-on-year increase of 13.86% [1] - The net profit for the year was HKD 156 million, a significant decrease of 79.69% compared to the previous year [1] - Basic earnings per share were reported at 1.4 HK cents [1] Group 2 - The company maximized production capacity for its amino acid business, resulting in a sales volume increase of approximately 36.6% to 522,000 metric tons, up from 382,000 metric tons in 2024 [1] - Due to intense domestic market competition, local suppliers are shifting to sell amino acid products in the domestic market [1] - The company plans to adjust amino acid production in the fourth quarter of 2025 to achieve optimal production rates in response to the oversupply of amino acid products in China [1]

Market Trends - The domestic market indices showed a slight decline, with the Shanghai Composite Index closing at 4,129.10, down 0.10%, while the Shenzhen Component Index fell by 0.63% [4][5]. Industry Commentary Chemical Raw Materials - The new materials sector experienced a decline of 5.28%, underperforming the ChiNext Index by 2.83%. Key segments such as semiconductor materials and electronic chemicals saw significant drops of 9.92% and 7.39%, respectively [6]. - The disruption of commercial shipping in the Strait of Hormuz due to geopolitical tensions has led to increased prices in the vitamin and amino acid sectors. For instance, the price of vitamin E rose by 11.76% to 66,500 CNY/ton, and methionine surged by 24.54% to 23,850 CNY/ton [6][7]. Communication Industry - Nvidia's strategic investment of $4 billion in optical communication firms Lumentum and Coherent highlights the importance of optical chips and modules in AI infrastructure. This investment aims to enhance domestic manufacturing capabilities in the U.S. [8]. - The "14th Five-Year Plan" emphasizes the significance of AI computing and satellite internet as key investment areas, with plans for large-scale projects in integrated circuits and satellite internet [8][9]. Textile and Apparel - The textile and apparel sector saw a decline of 2.8%, with specific sub-sectors like textile manufacturing and home textiles also experiencing downturns. Notably, On Running reported a 30% revenue increase for FY2025, with a projected 23% growth for FY2026 [11][15]. - Adidas reported record global revenue of 24.8 billion euros for 2025, marking a 13% increase, with significant growth in the Greater China region [14][15]. Company Commentary Zhongchumai (688267.SH) - Zhongchumai reported a historical high in performance, with a revenue of 856 million CNY for 2025, reflecting a 28.37% year-on-year increase, and a net profit of 212 million CNY, up 45.55% [18][20]. - The company is benefiting from increased demand for tail gas catalysts and has successfully expanded its product line through continuous R&D innovation [20][21].

Group 1: Overview of the Two Sessions - The growth target has been adjusted downwards from 5% to a range of 4.5-5%, with a continued focus on consumption and domestic demand [2][9] - Fiscal spending is expected to remain close to last year's levels, with a total deficit of 11.9 trillion yuan for 2026, comprising a deficit of 5.89 trillion yuan, special bonds of 4.4 trillion yuan, and special treasury bonds of 1.6 trillion yuan [2][9] - Special treasury bonds of 2.5 billion yuan will be allocated for new consumption, with an additional 1 billion yuan for fiscal-financial collaborative special funds [2][9] Group 2: Performance Trading Period Post Two Sessions - The correlation between market trading signals and performance changes will strengthen after the Two Sessions, with a focus on price increases and overseas expansion [3][13] - The upcoming month will see a concentrated disclosure of annual and quarterly reports, which will significantly influence market trading styles and directions [3][13] - High-prosperity industries are expected to focus on overseas "offensive HALO" and domestic "defensive HALO" strategies [3][15] Group 3: Impact of Rising Oil Prices on Asset Classes and Industries - During the oil price upcycle, stocks and commodities tend to perform well, with a monthly increase probability of 73% for stocks and 68% for commodities [4][26] - In contrast, during the downcycle, gold becomes a focus, with a monthly increase probability of 62% [4][26] - Key cyclical industries during the oil price upcycle include food and beverage, banking, automotive, home appliances, coal, and chemicals, which show significant cyclical characteristics [4][26] Group 4: Investment Strategy Directions - The report recommends focusing on "offensive HALO" strategies, which include price increases and overseas expansion in sectors such as TDI, amino acids, and high-end manufacturing [5] - Defensive HALO strategies involve sectors with low fund holdings, such as coal and construction, as well as TMT sectors with low correlation [5] - Emerging technology sectors like commercial aerospace, domestic computing power, and quantum communication are highlighted as potential catalysts for investment [5]

Group 1: Amino Acid Market Trends - Multiple amino acid prices in the Chinese market have increased, with methionine quoted at 18.8-19.2 CNY/kg and threonine at 7.4-7.8 CNY/kg[3] - The global pharmaceutical-grade amino acid market is projected to reach $1.14 billion in 2024 and $1.252 billion by 2031, with a CAGR of 1.4%[24] - Wuxi Jinghai, a leading player in the domestic amino acid market, reported a revenue of 406 million CNY in 2025, a 19.62% increase year-on-year[29] Group 2: Market Performance and Valuation - The median price change for consumer service stocks on the Beijing Stock Exchange was +0.77%, with 66% of companies experiencing an increase[37] - The total market capitalization of consumer service companies rose from 1074.91 billion CNY to 1077.02 billion CNY, while the median market cap decreased from 19.39 billion CNY to 19.24 billion CNY[41] - The median TTM P/E ratio for the consumer sector decreased from 52.0X to 50.9X, indicating a slight contraction in valuation[47] Group 3: Company Performance Highlights - Gai Shi Food achieved a revenue of 630.43 million CNY in 2025, up 18.01% year-on-year, with a net profit increase of 14.03%[55] - Vision Smart is expected to report a revenue of 301.88 million CNY in 2025, reflecting a 21.39% growth, with a net profit forecasted to rise by 41.07%[58] - Several companies, including Thunder God Technology and Qingju Technology, reported modest revenue growth, with increases of 2.93% and 0.89% respectively[55]

Core Insights - The "Top Ten Technological Advances in Inner Mongolia for 2025" has been officially announced, showcasing significant achievements in various fields including energy, new materials, biomedicine, and coal chemical engineering [1][2] Group 1: Technological Achievements - Successful development of the ultra-high voltage hybrid phase-shifting converter and application of the 720V solid-state sodium salt battery [1] - Breakthrough in wide power stability technology for alkaline electrolyzers at the kiloton level and establishment of a zero-carbon airport based on integrated wind-solar-storage-cooling-heating-electricity using transcritical carbon dioxide [1] - Scale development of 5N high-purity aluminum purification technology and over 20% improvement in magnetic powder utilization rate through enhanced manufacturing technology for rare earth permanent magnet materials [1] - Mass production of 10,000-ton G5 electronic-grade hydrochloric acid, marking a significant leap in high-end materials manufacturing [1] Group 2: Strategic Focus and Future Goals - Inner Mongolia's commitment to the "Technology Prosperity" strategy aims to achieve breakthroughs in key areas such as new energy, new materials, modern agriculture and animal husbandry, ecological protection, and life health by 2025 [2] - The advancements reflect Inner Mongolia's determination and effectiveness in driving development through innovation [2]

Core Insights - The collaboration between Baiwang Co., Ltd. and Anhui Huaheng Biotechnology Co., Ltd. aims to leverage AI technology to create intelligent financial and tax solutions, enhancing compliance and efficiency in financial digital transformation [1][2] Group 1: Company Profiles - Baiwang Co., Ltd. is a leading data intelligence enterprise in China, focusing on "data + AI" innovation, with a core asset of massive, real-time transaction data [1] - Anhui Huaheng Biotechnology Co., Ltd. is a high-tech enterprise specializing in synthetic biology, providing innovative and sustainable products in various fields such as animal nutrition and functional foods [1] Group 2: Collaboration Details - The partnership focuses on digital invoice management and electronic accounting file management, aiming to empower Huaheng's financial management system with intelligent upgrades [2] - Baiwang will assist Huaheng in building an integrated input invoice pool, automating the entire process of invoice collection, verification, and deduction certification, significantly enhancing management efficiency and data accuracy [2] - Baiwang's capabilities include multi-language invoice intelligent parsing, which will help Huaheng manage overseas invoices more effectively [2] Group 3: Future Directions - The collaboration is set to deepen in the field of financial digitalization, aiming to break down regional barriers and support Chinese enterprises in achieving compliant operations and efficient development in market competition [3]

Company Overview - Dongxiao Biotechnology Co., Ltd. announced plans to publicly issue up to 28,207,567 shares to unspecified qualified investors and list on the Beijing Stock Exchange [1] - The public shareholders will hold no less than 25% of the total share capital after the issuance [1] - The company may utilize an overallotment option, allowing for an additional issuance of up to 15% of the public offering shares [1] Fundraising Purpose - The funds raised will be allocated to projects including functional sugar alcohol industrial upgrade, high-value amino acid intelligent construction, innovation R&D base, and working capital supplementation [1] Industry Insights - The global amino acid market is expected to grow at a compound annual growth rate (CAGR) of 4.7% from 2022 to 2027, reaching a production scale of 13.8 million tons by 2027 [2] - In 2023, China's share of global feed amino acid production (including lysine, methionine, threonine, and tryptophan) is projected to increase to 70.4% [2] - The Chinese plant-based cream market is estimated to reach approximately 9.008 billion yuan in 2023, with a year-on-year growth of about 9.99% [2] Financial Performance - The company reported a revenue of 7.84 billion yuan and a net profit of 578 million yuan for the year 2024, reflecting a year-on-year increase of 93.98% [2]

Core Viewpoint - The article discusses a strategic cooperation agreement between Huaheng Biological and a research team led by Academician Yin Yulong, focusing on the innovative research and industrial application of amino acids in animal nutrition [1][3]. Group 1: Strategic Cooperation - The cooperation aims to advance research and development in amino acids for animal nutrition, with a focus on transforming research outcomes into efficient and environmentally friendly feed additives [3]. - The collaboration is expected to lead to breakthroughs in the application of amino acids in low-protein diets, precision feeding, and green farming, supporting sustainable development in the livestock industry [3]. Group 2: Company Overview - Huaheng Biological (688639.SH) is a high-tech enterprise centered on synthetic biology, specializing in green technology innovation and value creation, with main products including amino acids, vitamins, and bio-based materials [4]. - The company provides innovative and sustainable products and solutions for various fields, including intermediates, animal nutrition, personal care, plant nutrition, and functional foods [4].

Group 1 - The company Henan Zhongyuan Yuzhou Biotechnology Co., Ltd. has completed nearly 100 million RMB in angel round financing to accelerate the efficient green manufacturing of industrial heterologous enzymes and amino acids [1] - The financing round was led by Kailian Capital, with participation from Qingke Biotechnology and Zhengzhou High-tech Industrial Investment Fund, while existing shareholder Henan Investment Group Huirong Fund continued to increase its investment [1]